These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33321951)

  • 1. Potential of the Electronic Nose for the Detection of Respiratory Diseases with and without Infection.
    Licht JC; Grasemann H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic Nose Technology in Respiratory Diseases.
    Dragonieri S; Pennazza G; Carratu P; Resta O
    Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    Rocco G
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2622-2625. PubMed ID: 29602425
    [No Abstract]   [Full Text] [Related]  

  • 4. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
    Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breathprinting and Early Diagnosis of Lung Cancer.
    Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
    J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
    Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
    McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
    IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on electronic nose for diagnosis and monitoring treatment response in lung cancer.
    Vadala R; Pattnaik B; Bangaru S; Rai D; Tak J; Kashyap S; Verma U; Yadav G; Dhaliwal RS; Mittal S; Hadda V; Madan K; Guleria R; Agrawal A; Mohan A
    J Breath Res; 2023 Mar; 17(2):. PubMed ID: 36720157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic nose in discrimination of children with uncontrolled asthma.
    Tenero L; Sandri M; Piazza M; Paiola G; Zaffanello M; Piacentini G
    J Breath Res; 2020 Jul; 14(4):046003. PubMed ID: 32512553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
    de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
    J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions.
    Fens N; van der Schee MP; Brinkman P; Sterk PJ
    Clin Exp Allergy; 2013 Jul; 43(7):705-15. PubMed ID: 23786277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.